Literature DB >> 17462780

The modulating effects of the overexpression of uncoupling protein 2 on the formation of reactive oxygen species in vascular cells.

Hye-Soon Kim1, Keun-Gyu Park, Tae Bon Koo, Seung Huh, In-Kyu Lee.   

Abstract

Uncoupling protein 2 (UCP-2) is a newly identified member of the mitochondrial anion carrier family and shares 60% sequence identity with the well-characterized thermogenic UCP-1 from brown adipose tissue. Several lines of evidence suggest that UCP-2 is involved in the control of reactive oxygen species (ROS) production by mitochondria. More recently, a direct role for UCP-2 in the regulation of atherogenesis has been suggested by the observation that bone marrow transplantation from UCP-2-deficient mice to low-density lipoprotein receptor-deficient mice markedly increased atherosclerotic lesion size. This review introduces the possible role of UCP-2 in the regulation of atherogenesis in vascular cells. Although the relative contribution of the individual ROS generating systems in the vasculature is still ambiguous, both cell membrane NAD(P)H oxidase and the mitochondrial electron-transport chain have been proposed to play significant roles in the overproduction of ROS. UCP-2 can possibly modify atherosclerotic processes initiated in vascular cells and agents that increase UCP-2 expression in vascular cells may help prevent the development and progression of atherosclerosis in patients with diabetes or hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462780     DOI: 10.1016/j.diabres.2007.01.032

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  13 in total

1.  Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes.

Authors:  Michael E Widlansky; Jingli Wang; Sherene M Shenouda; Tory M Hagen; Anthony R Smith; Tinoy J Kizhakekuttu; Matthew A Kluge; Dorothee Weihrauch; David D Gutterman; Joseph A Vita
Journal:  Transl Res       Date:  2010-05-11       Impact factor: 7.012

Review 2.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.

Authors:  David M Krzywanski; Douglas R Moellering; Jessica L Fetterman; Kimberly J Dunham-Snary; Melissa J Sammy; Scott W Ballinger
Journal:  Lab Invest       Date:  2011-06-06       Impact factor: 5.662

3.  Deletion of mitochondrial uncoupling protein-2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines.

Authors:  Bryan A Haines; Suresh L Mehta; Serena M Pratt; Craig H Warden; P Andy Li
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

4.  Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose.

Authors:  Mohamad Hafizi Abu Bakar; Nany Hairunisa; Hasniza Zaman Huri
Journal:  Clin Exp Med       Date:  2018-03-17       Impact factor: 3.984

5.  Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress.

Authors:  Matthew Blatnik; Norma Frizzell; Suzanne R Thorpe; John W Baynes
Journal:  Diabetes       Date:  2007-10-12       Impact factor: 9.461

Review 6.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

7.  Overexpression of mitochondrial uncoupling protein 2 inhibits inflammatory cytokines and activates cell survival factors after cerebral ischemia.

Authors:  Bryan Haines; P Andy Li
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

8.  Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1.

Authors:  Fengrong Jiang; Rilei Jiang; Xiaojia Zhu; Xu Zhang; Zhan Zhan
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients.

Authors:  Emanuela Lapice; Michele Pinelli; Elisabetta Pisu; Antonella Monticelli; Roberto Gambino; Gianfranco Pagano; Silvia Valsecchi; Sergio Cocozza; Gabriele Riccardi; Olga Vaccaro
Journal:  Cardiovasc Diabetol       Date:  2010-10-28       Impact factor: 9.951

10.  Antagonistic effect of TNF-alpha and insulin on uncoupling protein 2 (UCP-2) expression and vascular damage.

Authors:  Almudena Gómez-Hernández; Liliana Perdomo; Natalia de las Heras; Nuria Beneit; Oscar Escribano; Yolanda F Otero; Carlos Guillén; Sabela Díaz-Castroverde; Beatriz Gozalbo-López; Victoria Cachofeiro; Vicente Lahera; Manuel Benito
Journal:  Cardiovasc Diabetol       Date:  2014-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.